Sofie Co
#12,254 by obligations / 45.4/100 Score / $2.9M obligated (FY24+) / 32 awards / 68.4% no-bid among largest contracts / Jun 4, 2026 latest action
Executive Capture & Competitive PositionWhat this company is, who pays it, where it can grow or lose
Market RoleEmerging EntrantNot in Top 100 directory
Company Score & Key Metrics#12,254 by obligations / Small contractor
SAM.gov registration and exclusionsChecked 2026-11-12 / About this data
No active exclusion found for this UEI, CAGE or legal name.
| Registration | Active / All awards / expires 2027-10-21 |
|---|---|
| Legal name | SOFIE CO. (DBA IBA MOLECULAR) |
| Address | 21000 ATLANTIC BLVD, SUITE 730, DULLES, VA, 20166, USA / district 10 |
| Structure | Corporate entity (not tax exempt), incorporated in VA / in business since 1995-10-08 |
| NAICS | 325412 (+1 more) |
| API | registration JSON / SAM.gov record |
Contracts & Orders32 available contract records (FY2024+), largest first
| Contract ID | Obligated (FY24+) | Type | Agency | Category | Description | Latest Action |
|---|---|---|---|---|---|---|
| HT001426FE014 | $250K | BPA call | Defense Health Agency | Drugs and biologicals | Bpa call order for radioactive pharmaceuticals required for positron emission tomography (pet). | Jan 7, 2026 |
| HT001424F0057 | $249K | BPA call | Defense Health Agency | Drugs and biologicals | Life molecular imaging product neurace | May 15, 2024 |
| HT001424F0118 | $249K | BPA call | Defense Health Agency | Drugs and biologicals | Life molecular imaging product | Jul 26, 2024 |
| HT001425F0019 | $249K | BPA call | Defense Health Agency | Drugs and biologicals | Radiopharmaceuticals | Jan 15, 2025 |
| HT001423P0165 | $249K | purchase order | Defense Health Agency | Drugs and biologicals | Pyl-c pylarify f-18 piflufolastat | Jan 19, 2024 |
| HT001425F0044 | $249K | BPA call | Defense Health Agency | Drugs and biologicals | Neuraceq radiopharmaceutical for positron emission tomography scans | May 1, 2025 |
| HT001425F0050 | $246K | BPA call | Defense Health Agency | Drugs and biologicals | Pylarify f 18 injection for pet scan imaging of the prostate. | Apr 18, 2025 |
| HT001426FE062 | $245K | BPA call | Defense Health Agency | Drugs and biologicals | Acquisition of neuraceq (florbetaben f18). | Jun 4, 2026 |
| W81K0024F0075 | $197K | BPA call | Department of the Army | Drugs and biologicals | Various radiopharmacueticals | Nov 7, 2024 |
| W81K0025PA260 | $188K | purchase order | Department of the Army | Drugs and biologicals | Radiopharmaceuticals requirement is necessary to support the department of radiology, nuclear medicine clinic. | Dec 18, 2025 |
| W81K0023F0141 | $100K | BPA call | Department of the Army | Drugs and biologicals | Radiopharmaceuticals for bamc | Jul 23, 2024 |
| HT009025FG0610064 | $44K | BPA call | Defense Health Agency | Drugs and biologicals | Radio-pharmaceuticals | May 27, 2025 |
| HT009025FG081100 | $44K | BPA call | Defense Health Agency | Drugs and biologicals | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment sofie (s0f-neuraceq) | Jul 23, 2025 |
| HT009024FG0910085 | $36K | BPA call | Defense Health Agency | Drugs and biologicals | Radiopharmaceutical. | Sep 9, 2024 |
| HT009026FG1110036 | $36K | BPA call | Defense Health Agency | Drugs and biologicals | Pharmaceuticals needed for patient care. | Nov 4, 2025 |
| HT009024FG0510058 | $32K | BPA call | Defense Health Agency | Drugs and biologicals | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment | May 21, 2024 |
| HT009025FG0310056 | $29K | BPA call | Defense Health Agency | Health care services | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment | Mar 20, 2025 |
| HT009025FG0310051 | $25K | BPA call | Defense Health Agency | Drugs and biologicals | "radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment. | Mar 5, 2025 |
| HT009025FG1210047 | $25K | BPA call | Defense Health Agency | Drugs and biologicals | Radiopharmaceutical needed for prostate cancer patients with metastatic lesions after definite treatment | Dec 19, 2024 |
| HT009026FG1210062 | $25K | BPA call | Defense Health Agency | Instruments and lab equipment | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment | Dec 2, 2025 |
| HT009026FG0210049 | $22K | BPA call | Defense Health Agency | Drugs and biologicals | Radio-pharmaceutical for patient care. | Feb 4, 2026 |
| HT009025FG0210044 | $22K | BPA call | Defense Health Agency | Drugs and biologicals | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment | Feb 10, 2025 |
| HT009025FG0710073 | $14K | BPA call | Defense Health Agency | Health care services | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment | Jun 24, 2025 |
| HT009025FG0820120 | $14K | BPA call | Defense Health Agency | Health care services | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment | Aug 20, 2025 |
| HT009024FG0510042 | $11K | BPA call | Defense Health Agency | Drugs and biologicals | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment | May 9, 2024 |
| HT009024FG0610050 | $11K | delivery order | Defense Health Agency | Drugs and biologicals | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment. | Jun 26, 2024 |
| HT009024FG0810071 | $11K | BPA call | Defense Health Agency | Medical equipment and supplies | Radiopharmaceutical required for patient care. | Aug 13, 2024 |
| HT009026FG0110043 | $11K | BPA call | Defense Health Agency | Drugs and biologicals | Radiopharmaceutical needed for prostate cancer patient. | Dec 26, 2025 |
| HT001424A0002 | $0 | blanket purchase agreement | Defense Health Agency | Drugs and biologicals | Master blanket purchase agreement for pharmaceutical supplies. | Dec 23, 2025 |
| W81K0020A0016 | $0 | blanket purchase agreement | Department of the Army | Medical equipment and supplies | Provide radiopharmaceutical to mtfs | Oct 23, 2023 |
| W81K0023F0091 | $0 | BPA call | Department of the Army | Medical equipment and supplies | Radiopharmaceuticals | Feb 13, 2024 |
| HT001421P0008 | -$2K | purchase order | Defense Health Agency | Medical equipment and supplies | The requirement of f-18 "neuraceq", is a nuclear medicine pet use to imaging the brain to estimate amyloid neuritic plaque density in adult patients at walter reed national military medical center. | Jul 25, 2024 |
Contract Vehicles (IDIQ & BPA)4 parent contract vehicles
| # | Parent Contract ID | Task Orders | Obligated (FY24+) | Vehicle Ceiling | Unused Ceiling | Description | Latest Order |
|---|---|---|---|---|---|---|---|
| 1 | HT001424A0002 | 21 | $2.1M | $250K | - | Radiopharmaceuticals | Jun 4, 2026 |
| 2 | W81K0020A0016 | 3 | $297K | $197K | - | Various radiopharmacueticals | Nov 7, 2024 |
| 3 | HT001421A0014 | 2 | $43K | $32K | - | Radiopharmaceutical required for patient care. | Aug 13, 2024 |
| 4 | 36C25524D0411 | 1 | $11K | $11K | - | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment. | Jun 26, 2024 |
Unused ceiling is uncommitted capacity across available contract records, not guaranteed spending. Vehicle details summarize the largest 500 records.
Buying AgenciesFY2024+
| # | Agency | Awards | Obligated | Share |
|---|---|---|---|---|
| 1 | Defense Health Agency | 27 | $2.4M | 83% |
| 2 | Department of the Army | 5 | $485K | 17% |
Product & Service CategoriesFY2024+
| # | Category | Awards | Obligated | Share |
|---|---|---|---|---|
| 1 | Drugs and biologicals | 24 | $2.8M | 97% |
| 2 | Health care services | 3 | $58K | 2.0% |
| 3 | Instruments and lab equipment | 1 | $25K | 0.9% |
| 4 | Medical equipment and supplies | 4 | $9K | 0.3% |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 24, 2026.
Export Custom Datasets or Query the AwardTape API
Select from 6 core datasets (Contractors, Contract Instruments, Expiring Recompetes, Allied Procurement, HV Grid Queue, Sanctions/UFLPA), filter by company, ticker, or PIID, and export in CSV, JSON, or Markdown Brief.
Building an AI agent? Get this company profile as JSON: GET /api/agent/v1/companies/sofie. Schema, sample and price or start with free sample calls.